期刊
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
卷 73, 期 4, 页码 361-364出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.diagmicrobio.2012.05.007
关键词
Pseudomonas aeruginosa; Antimicrobial susceptibility; Multidrug-resistant
Broth microdilution (Clinical and Laboratory Standards Institute) was used to evaluate the antimicrobial susceptibility of 1549 Pseudomonas aeruginosa clinical isolates collected in Canada between January 2008 and October 2011. The percentage of isolates susceptible was as follows: amikacin 92.0%, ceftazidime 83.5%, ciprofloxacin 74.3%, colistin 93.4%, gentamicin 76.8%, meropenem 82.7%, and piperacillin-tazobactam 83.6%. Antimicrobial susceptibility did not change significantly between 2008 and 2011, with the exception of increasing susceptibility to gentamicin (P < 0.0001). (C) 2012 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据